237 related articles for article (PubMed ID: 10207098)
1. Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction.
Knoblauch R; Garabedian MJ
Mol Cell Biol; 1999 May; 19(5):3748-59. PubMed ID: 10207098
[TBL] [Abstract][Full Text] [Related]
2. Genetic dissection of p23, an Hsp90 cochaperone, reveals a distinct surface involved in estrogen receptor signaling.
Oxelmark E; Knoblauch R; Arnal S; Su LF; Schapira M; Garabedian MJ
J Biol Chem; 2003 Sep; 278(38):36547-55. PubMed ID: 12835317
[TBL] [Abstract][Full Text] [Related]
3. Cooperation of heat shock protein 90 and p23 in aryl hydrocarbon receptor signaling.
Cox MB; Miller CA
Cell Stress Chaperones; 2004 Mar; 9(1):4-20. PubMed ID: 15270073
[TBL] [Abstract][Full Text] [Related]
4. Genetic and biochemical analysis of p23 and ansamycin antibiotics in the function of Hsp90-dependent signaling proteins.
Bohen SP
Mol Cell Biol; 1998 Jun; 18(6):3330-9. PubMed ID: 9584173
[TBL] [Abstract][Full Text] [Related]
5. Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cells.
Simpson NE; Gertz J; Imberg K; Myers RM; Garabedian MJ
Mol Endocrinol; 2012 Jan; 26(1):194-202. PubMed ID: 22074947
[TBL] [Abstract][Full Text] [Related]
6. Probing the structure and function of the estrogen receptor ligand binding domain by analysis of mutants with altered transactivation characteristics.
Eng FC; Lee HS; Ferrara J; Willson TM; White JH
Mol Cell Biol; 1997 Aug; 17(8):4644-53. PubMed ID: 9234721
[TBL] [Abstract][Full Text] [Related]
7. High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance.
Simpson NE; Lambert WM; Watkins R; Giashuddin S; Huang SJ; Oxelmark E; Arju R; Hochman T; Goldberg JD; Schneider RJ; Reiz LF; Soares FA; Logan SK; Garabedian MJ
Cancer Res; 2010 Nov; 70(21):8446-56. PubMed ID: 20847343
[TBL] [Abstract][Full Text] [Related]
8. The p23 molecular chaperones act at a late step in intracellular receptor action to differentially affect ligand efficacies.
Freeman BC; Felts SJ; Toft DO; Yamamoto KR
Genes Dev; 2000 Feb; 14(4):422-34. PubMed ID: 10691735
[TBL] [Abstract][Full Text] [Related]
9. Interaction and dissociation by ligands of estrogen receptor and Hsp90: the antiestrogen RU 58668 induces a protein synthesis-dependent clustering of the receptor in the cytoplasm.
Devin-Leclerc J; Meng X; Delahaye F; Leclerc P; Baulieu EE; Catelli MG
Mol Endocrinol; 1998 Jun; 12(6):842-54. PubMed ID: 9626660
[TBL] [Abstract][Full Text] [Related]
10. Hormone-dependent transactivation by estrogen receptor chimeras that do not interact with hsp90. Evidence for transcriptional repressors.
Lee HS; Aumais J; White JH
J Biol Chem; 1996 Oct; 271(42):25727-30. PubMed ID: 8824196
[TBL] [Abstract][Full Text] [Related]
11. Intracellular dynamics of the Hsp90 co-chaperone p23 is dictated by Hsp90.
Picard D
Exp Cell Res; 2006 Jan; 312(2):198-204. PubMed ID: 16289154
[TBL] [Abstract][Full Text] [Related]
12. Selective interaction of hsp90 with an estrogen receptor ligand-binding domain containing a point mutation.
Aumais JP; Lee HS; Lin R; White JH
J Biol Chem; 1997 May; 272(18):12229-35. PubMed ID: 9115298
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
14. Yeast two-hybrid system demonstrates that estrogen receptor dimerization is ligand-dependent in vivo.
Wang H; Peters GA; Zeng X; Tang M; Ip W; Khan SA
J Biol Chem; 1995 Oct; 270(40):23322-9. PubMed ID: 7559488
[TBL] [Abstract][Full Text] [Related]
15. p23/Sba1p protects against Hsp90 inhibitors independently of its intrinsic chaperone activity.
Forafonov F; Toogun OA; Grad I; Suslova E; Freeman BC; Picard D
Mol Cell Biol; 2008 May; 28(10):3446-56. PubMed ID: 18362168
[TBL] [Abstract][Full Text] [Related]
16. Role of HSP90 in mediating cross-talk between the estrogen receptor and the Ah receptor signal transduction pathways.
Caruso JA; Laird DW; Batist G
Biochem Pharmacol; 1999 Nov; 58(9):1395-403. PubMed ID: 10513983
[TBL] [Abstract][Full Text] [Related]
17. The cochaperone p23 differentially regulates estrogen receptor target genes and promotes tumor cell adhesion and invasion.
Oxelmark E; Roth JM; Brooks PC; Braunstein SE; Schneider RJ; Garabedian MJ
Mol Cell Biol; 2006 Jul; 26(14):5205-13. PubMed ID: 16809759
[TBL] [Abstract][Full Text] [Related]
18. Control of estrogen receptor ligand binding by Hsp90.
Fliss AE; Benzeno S; Rao J; Caplan AJ
J Steroid Biochem Mol Biol; 2000 Apr; 72(5):223-30. PubMed ID: 10822011
[TBL] [Abstract][Full Text] [Related]
19. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery.
Pratt WB; Toft DO
Exp Biol Med (Maywood); 2003 Feb; 228(2):111-33. PubMed ID: 12563018
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal adenosine triphosphate binding domain of Hsp90 is necessary and sufficient for interaction with estrogen receptor.
Bouhouche-Chatelier L; Chadli A; Catelli MG
Cell Stress Chaperones; 2001 Oct; 6(4):297-305. PubMed ID: 11795466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
